168 studies found for:    Open Studies | "Niacin"
Show Display Options
Rank Status Study
21 Not yet recruiting Postprandial Fatty Acid Metabolism in the Natural History of Type 2 Diabetes (T2D)
Condition: Impaired Glucose Tolerance
Interventions: Drug: Nicotinic acid;   Other: [7,7,8,8-2H]-palmitate;   Other: [U-13C]-palmitate;   Procedure: Biopsy;   Other: liquid meal
22 Unknown  Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT)
Conditions: Dyslipidemia;   Atherosclerosis
Interventions: Drug: simvastatin;   Drug: Nicotinic Acid
23 Recruiting The Topical Niacin Skin Flush Test in First Episode Psychosis
Conditions: Psychotic Disorders;   Schizophrenia
Intervention: Other: skin test
24 Unknown  Assessing the Effects of a Topically Applied Cream to Clitoral Blood Flow
Condition: Female Sexual Dysfunction
Interventions: Drug: arginine 20%, nicotinamide .01%, niacin.1%, in LipodermPG 50%;   Drug: Topical study cream;   Drug: GRAS cream
25 Recruiting Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)
Condition: Dyslipidemia
Interventions: Drug: ALIROCUMAB SAR236553 (REGN727);   Drug: placebo;   Drug: statins;   Drug: ezetimibe;   Drug: fenofibrate;   Drug: nicotinic acid;   Drug: omega-3 fatty acids
26 Recruiting A Study Investigating the Effects of Niagen™ in Healthy Adults.
Condition: Bioavailability
Interventions: Dietary Supplement: Niagen™ 100;   Dietary Supplement: Niagen™ 300;   Dietary Supplement: Niagen™ 1000;   Other: Placebo
27 Recruiting Lao Zinc Study: Effects of Two Forms of Daily Preventive Zinc Versus Therapeutic Zinc Supplementation
Condition: Diarrhea
Interventions: Dietary Supplement: MNP;   Dietary Supplement: preventive zinc supplement;   Dietary Supplement: therapeutic zinc supplement;   Dietary Supplement: preventive placebo supplement;   Dietary Supplement: therapeutic placebo supplement;   Dietary Supplement: placebo powder
28 Recruiting A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High Risk Patients With Hypertriglyceridemia and on Statin. The Primary Objective is to Evaluate the Effect of 4 g/Day AMR101 for Preventing the Occurrence of a First Major Cardiovascular Event.
Condition: Cardiovascular Diseases
Interventions: Drug: AMR101;   Drug: Placebo
29 Unknown  A Study on Psychopathological Progress of Early Schizophrenia-Like Disorder (SOPRES)
Condition: Schizophrenia
Intervention:
30 Recruiting Multi-micronutrient Supplementation During Peri-conception and Congenital Heart Disease
Condition: Congenital Heart Disease
Interventions: Dietary Supplement: Vitamin B Complex and Folic Acid;   Dietary Supplement: Iron and Folic Acid;   Dietary Supplement: Folic Acid
31 Unknown  Study to Evaluate the Efficacy and Tolerability of Apevinat BC Compared to Vitamin Complex
Conditions: Lack of Appetite;   Anorexia
Interventions: Drug: Apevinat BC;   Drug: Vitamin Complex
32 Recruiting Iron Absorption From a Micronutrient Powder Containing Galacto-oligosaccharides (GOS)
Condition: Anemia, Iron-Deficiency
Interventions: Dietary Supplement: Fortified maize porridge (MNP+iron);   Dietary Supplement: Fortified maize porridge (MNP+iron+GOS)
33 Recruiting Comparison of Two Nutrition Interventions in Young Children in El Salvador
Condition: Micronutrient Deficiency
Interventions: Dietary Supplement: 21 micronutrient-fortified supplement;   Dietary Supplement: Cereal Fortificado (Fortified Cereal);   Dietary Supplement: Ferrous sulphate;   Dietary Supplement: Vitamin A
34 Recruiting A Study to Evaluate Safety and Health Benefits of Basis™ Among Elderly Subjects.
Condition: Safety: Healthy Subjects
Interventions: Dietary Supplement: Basis 250;   Dietary Supplement: Basis 500;   Dietary Supplement: Placebo
35 Unknown  Prostate Cancer Prevention Trial With Quercetin and Genistein
Condition: Primary Prevention of Prostate Cancer
Interventions: Dietary Supplement: Quercetin supplement;   Dietary Supplement: Genistein supplement;   Dietary Supplement: Placebo
36 Recruiting Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia
Condition: Hyperlipidemia
Intervention: Drug: ARI-3037MO
37 Unknown  Effect of Micronutrients and Exercise During Pregnancy on Factors Related With Non-Transmissible Chronic Diseases
Conditions: Preeclampsia;   Pregnancy;   Micronutrients;   Exercise
Interventions: Behavioral: Regular aerobic physical exercise;   Dietary Supplement: Micronutrients;   Other: Activities of daily living + placebo
38 Not yet recruiting Early Child Development and Nutrition in Guatemala
Condition: Undernutrition
Interventions: Dietary Supplement: Micronutrients;   Behavioral: Responsive feeding;   Dietary Supplement: Placebo
39 Not yet recruiting Correlation Between Sorafenib Plasma Concentrations, Toxicity and Disease Control Rate in Patients Treated by Sorafenib for Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma (HCC)
Intervention: Biological: Sorafenib plasma concentration 4 weeks after treatment initiation
40 Recruiting Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition: Untreated Adult Acute Myeloid Leukemia
Interventions: Drug: Cytarabine;   Drug: Dasatinib;   Drug: Idarubicin;   Other: Laboratory Biomarker Analysis;   Drug: Nilotinib;   Drug: Ponatinib Hydrochloride;   Drug: Sorafenib Tosylate;   Drug: Sunitinib Malate

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years